The largest community of pharma leaders

SignalPath Expands Leadership Team with Key Hire to Lead Finance

RALEIGH, N.C.–()–SignalPath today announced that Daniel Janick has joined SignalPath as Senior Vice President of Finance, to support the explosive growth of the SignalPath platform across both its site and sponsor client segments.

“I am encouraged to see the continued adoption of our site-facing CTMS platform across a broad spectrum of sites, health systems, and academic medical centers over the last several months,” says Dr. Brad Hirsch, Chief Executive Officer at SignalPath. “Now that we are beginning to see similar excitement with our sponsor-facing tools, it became clear that we needed to augment our leadership team with someone with deep strategic finance expertise.”

Dan brings to SignalPath a 30-year track record of successfully building enterprise value and driving execution for tech-enabled businesses as a C-suite leader, board member, investor, and financial advisor. Most recently, Dan served for eight years as Chief Operations Officer and Chief Financial Officer at Academic Analytics where he helped lead the technology company’s transition from early stage to sustainable growth and profitability. Dan also has extensive experience in private equity and investment banking where he has spent his career doing strategic investments, mergers, and acquisitions.

“SignalPath’s vision for bringing innovative technology solutions to the clinical research market could not be more relevant given the challenges of the current global pandemic,” says Dan Janick. “I’m excited to join SignalPath’s dynamic leadership team and be part of the company’s next phase of aggressive growth.”

About SignalPath: SignalPath is the premier clinical trial technology partner for research sites and sponsors, focused on improving the ease and efficiency of trial execution and management. Supporting over 2,500 trials across 300 sites and 3,000 active users, SignalPath is the industry standard that addresses key pain points in the conduct of trials. To learn more about SignalPath’s site and trial solutions, please visit


Recent Articles

Sperm Bank Market: COVID-19 Business Continuity Plan | Evolving Opportunities with Androcryos and Cryos International-Denmark ApS | Technavio

LONDON--(BUSINESS WIRE)-- #GlobalSpermBankMarket--The Global Sperm Bank Market will grow by $...

Global Hereditary Transthyretin Amyloidosis (hATTR) Competitive Landscape, Market Insights, Epidemiology and Forecast 2017-2020 & 2030 –

DUBLIN--(BUSINESS WIRE)--The "Hereditary Transthyretin Amyloidosis (hATTR) - Competitive Landscape, Market Insights,...

Strive Health Welcomes David Thornton as Chief People Officer

DENVER--(BUSINESS WIRE)-- #executiveteam--Leading specialized kidney care company Strive Health today announced...

Accenture Puts Data Science to Work for Pediatric Leukemia Research

NEW YORK--(BUSINESS WIRE)--Accenture has built a data and analytics approach to...

FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome

CLEVELAND--(BUSINESS WIRE)---- $ATHX #ARDS--MultiStem is the only cell therapy program for...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.